EVE Health Group Limited (ASX: EVE)
Sector: Financials
Market cap: A$5M (as of 2 Nov 2026)
EVE Health Group (ASX: EVE) is an Australian life sciences company developing and commercialising innovative pharmaceutical products in high-growth therapeutic areas. Its lead assets, Dyspro and Libbo, utilise proprietary delivery technologies to improve
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 28 Oct 2026 | A-WON PHARMA PTY LTD | Increase | 14.8% → 16.31% | Filing ↗ |
| 28 Apr 2026 | A-WON PHARMA PTY LTD | Increase | 13.25% → 14.8% | Filing ↗ |
| 20 Apr 2026 | AQA Corporation Pty Ltd <The Renaissance S/F A/C> | Decrease | 7.250% → 5.879% | Filing ↗ |
| 20 Apr 2026 | A-WON PHARMA PTY LTD | Increase | 8.95% → 13.25% | Filing ↗ |
| 8 Apr 2026 | A-WON PHARMA PTY LTD | Increase | 8.95% → 31.485387% | Filing ↗ |
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 26 Oct 2026 | Stuart Gunzburg | Bought 400,000 | Filing ↗ |
| 2 Jan 2026 | Stuart Gunzburg | Bought 200,000 Ordinary Shares | Filing ↗ |
| 15 Dec 2025 | Stuart Gunzburg | Bought 125,000 Ordinary Shares | Filing ↗ |
| 17 June 2025 | Stuart Gunzburg | Bought 279,482 | Filing ↗ |
| 29 Dec 2021 | Mr Gregory William Fry | Bought 1,800,000 | Filing ↗ |
Cash and runway
Ask about EVE in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has EVE raised money in the last year, and at what discount?
- What was EVE's latest cash position and runway?
Loading EVE…